Ammar M. Killu,Elad Maor,Rick A. Nishimura,Samuel J. Asirvatham,Amir Lerman
申请号：
US15968383
公开号：
US20180318003A1
申请日:
2018.05.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Devices and methods can be used to treat heart conditions such as hypertrophic cardiomyopathy (HCM). For example, this document describes transcatheter myocardial volume reduction devices and methods for treating HCM. In some implementations described in this document, a transcatheter irreversible electroporation (IRE) technique is used to treat HCM. In some cases, such a technique is used to deliver non-thermal ablation to myocardial cellular components such as the ventricular septum. The bulk of the ventricular septums myocardial tissue can be reduced in result.
